Boundless Bio, Inc. (BOLD) vs Clene Inc. (CLNN)
Boundless Bio, Inc. and Clene Inc. are both Biotechnology companies. Boundless Bio, Inc. and Clene Inc. are of similar size ($59.8M and $59.1M). Boundless Bio, Inc. has the higher net margin (0.00% vs −20,059.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Clene Inc. leads on 6 and Boundless Bio, Inc. on 5.
Valuation
Profitability
| Metric | BOLD | CLNN | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 70.05% | 65.16% |
| Operating margin | 0.00% | (10,431.98%) | 0.00% |
| Net margin | 0.00% | (20,059.90%) | 0.00% |
| Free cash flow margin | 0.00% | (8,095.43%) | 0.00% |
| Return on equity | (67.86%) | 237.15% | (57.72%) |
| Return on assets | (50.56%) | (174.99%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack